M0223 Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

Short descriptor: Bebtelovimab injection home

⚠ Terminated HCPCS Level II 2026
Terminated Code
M0223 was terminated as of 2024-12-12 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open M0223 in the app →

Look up M0223 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

M0223 is the HCPCS Level II code for Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Vaccinations.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Vaccinations (indicator 54)
Type of Service
Pneumococcal/flu/hepatitis B vaccine
Effective Date
2024-12-13
Termination Date
2024-12-12
2026 Maintenance
No change this year

References

Cite This Page

Reference M0223 with the canonical source and edition:

M0223 — Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M0223

Canonical URL: https://icd10codingpro.com/hcpcs-codes/M0223

Related Codes in Section M

← M0222 Bebtelovimab injection M0224 → Pemivibart infusion
M0201 Pne flu hepb cov home admin M0220 Tixagev and cilgav inj M0221 Tixagev and cilgav inj hm M0222 Bebtelovimab injection M0224 Pemivibart infusion M0235 Intrav inf, mon anti, fir do M0236 Intrav inf, mon anti, sec do M0237 Intrav inf, toci, first dose M0238 Intrav inf, toci, second dos M0239 Bamlanivimab-xxxx infusion
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial